Alternative statutory remedy and unexplained delay barred writ review of customs confiscation adjudication, leaving merits for appellate consideration...
Authorised courier due diligence protects against penalties where declared exports conceal prohibited goods despite proper documentation and customs p...
Customs-controlled container movement now extends to DP World facilities, subject to segregation, inspections, reconciliation, and EXIM cargo priority...
DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 (formerly Para 2.90A of HBP 2015-2020) regarding Track and Trace system for export of drug formulations, exercising powers under Paragraphs 1.03 and 2.04 of Foreign Trade Policy 2023. The responsibility for implementing authentication systems for exported drug formulations now transfers to Ministry of Health and Family Welfare, to be administered under Drug Rules 1945. The withdrawal takes immediate effect, marking a significant shift in regulatory oversight of pharmaceutical exports from trade authorities to healthcare regulators.
DGFT has withdrawn Para 2.76 of Handbook of Procedures 2023 (formerly Para 2.90A of HBP 2015-2020) regarding Track and Trace system for export of drug formulations, exercising powers under Paragraphs 1.03 and 2.04 of Foreign Trade Policy 2023. The responsibility for implementing authentication systems for exported drug formulations now transfers to Ministry of Health and Family Welfare, to be administered under Drug Rules 1945. The withdrawal takes immediate effect, marking a significant shift in regulatory oversight of pharmaceutical exports from trade authorities to healthcare regulators.
Note: It is a system-generated summary and is for quick reference only.